When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Absence seizures

Last reviewed: 3 Dec 2025
Last updated: 27 Nov 2025

Summary

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • family history of childhood seizures
  • staring episode, lasting 5 to 10 seconds; several times per day with no aura/postictal state
  • childhood onset
  • normal physical exam
  • hyperventilation-induced seizure
Todos los datos

Otros factores de diagnóstico

  • automatisms
  • recent decline in school performance
  • early onset (before age 4 years)
Todos los datos

Factores de riesgo

  • family/genetic history of absence epilepsy syndrome
  • acquired brain injury: for example, hypoxia-ischemia, trauma, infection
  • other congenital inborn errors of metabolism, structural defects, chromosomal abnormalities
  • developmental delay or intellectual disability
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • EEG
Todos los datos

Pruebas diagnósticas que deben considerarse

  • MRI brain
  • testing for metabolic disorders (e.g., serum amino acids, urine organic acids, lactate pyruvate or specific enzymatic tests)
  • cerebrospinal fluid glucose and serum glucose
  • genetic testing
Todos los datos

Algoritmo de tratamiento

Agudo

typical absence seizures without a history of generalized tonic-clonic seizures (childhood absence epilepsy)

typical absence seizures with a history of generalized tonic-clonic seizures (CAE, JAE, JME)

atypical absence seizures

En curso

refractory to treatment

Colaboradores

Autores

Emily McGinnis, MD

Clinical Assistant Professor

Department of Clinical Science

Kaiser Permanente Bernard J. Tyson School of Medicine

Los Angeles

CA

Divulgaciones

EM states that she has no competing interests.

Dean Sarco, MD

Clinical Associate Professor

Department of Clinical Science

Kaiser Permanente Bernard J. Tyson School of Medicine

Los Angeles

CA

Divulgaciones

DS states that he has no competing interests.

Agradecimientos

Dr Emily McGinnis and Dr Dean Sarco would like to gratefully acknowledge Dr Michael Wong and Dr Judith L. Z. Weisenberg, previous contributors to this topic.

Divulgaciones

MW and JLZW declare that they have no competing interests.

Revisores por pares

Anita Devlin, MBBS, MD

Consultant Paediatric Neurologist

Royal Victoria Infirmary

NHS Foundation Trust

Newcastle-upon-Tyne

UK

Divulgaciones

AD and two epilepsy nurses from her department have been reimbursed by UCB Pharma, the manufacturer of levetiracetam, for attending several conferences. One of the epilepsy nurses received a one-off sponsorship payment from UCB Pharma to cover the initial set-up costs of the adolescent epilepsy support group. One epilepsy nurse has been reimbursed by Cyberonics, the manufacturer of vagal nerve stimulators, for attending one or more conferences.

Cigdem Akman, MD

Division of Pediatric Neurology

Columbia University College of Physicians and Surgeons

New York

NY

Divulgaciones

CA declares that he has no competing interests.

Angus A. Wilfong, MD

Associate Professor

Pediatrics and Neurology

Baylor College of Medicine

Medical Director

Comprehensive Epilepsy Program

Texas Children's Hospital

Houston

TX

Divulgaciones

AAW declares that he has no competing interests.

Helen Cross, MB, ChB, PhD, FRCP, FRCPCH

Head of Neurosciences Unit

The Prince of Wales’s Chair of Childhood Epilepsy

National Centre for Young People with Epilepsy

London

UK

Divulgaciones

HC has received research funds from HAS, Epilepsy Research UK, SHS, and the Milk Development Council. She has received funding for an epilepsy training fellowship from UCB and Eisai. She has also received travel funding from Eisai, UCB, and GlaxoSmithKline.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Beniczky S, Trinka E, Wirrell E, et al. Updated classification of epileptic seizures: position paper of the International League Against Epilepsy. Epilepsia. 2025 Jun;66(6):1804-23.Texto completo  Resumen

Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017 Apr;58(4):512-21.Texto completo  Resumen

Hirsch E, French J, Scheffer IE, et al. ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE task force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1475-99.Texto completo  Resumen

Specchio N, Wirrell EC, Scheffer IE, et al. International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1398-442.Texto completo  Resumen

Brigo F, Igwe SC, Lattanzi S. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev. 2021 Jan 21;1(1):CD003032.Texto completo  Resumen

Rinaldi VE, Di Cara G, Mencaroni E, et al. Therapeutic options for childhood absence epilepsy. Pediatr Rep. 2021 Dec 16;13(4):658-67.Texto completo  Resumen

Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018 Jul 10;91(2):74-81.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Diferenciales

    • Daydreaming
    • Attention deficit hyperactivity disorder (ADHD)
    • Focal impaired awareness seizures of frontal or temporal lobe origin
    Más Diferenciales
  • Guías de práctica clínica

    • Epilepsies in children, young people and adults
    • Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication
    Más Guías de práctica clínica
  • Folletos para el paciente

    Absence seizures in children

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad